TrialResults - center   -  Clinical trials results database in cardiology

GAMMA

You are here:  Home > naftopidil in cardiovascular prevention

naftopidil in cardiovascular prevention - Clinical trials results

Systematic review and meta-analysis of clinical trials about naftopidil in cardiovascular prevention.

Clinical trials enrolled the following type of patients :

diabetic patients

all type of patients

secondary prevention in patients with intermittent claudication

secondary prevention in patients with CAD

primary prevention

patients without established disease

See also:

• antiplatelets drug (all clinical conditions)
• cardiovascular prevention (all therapeutical action or mecanism)
• Other antiplatelets drug:  aspirin , aspirin + dypiridamol , aspirine , cangrelor , cangrelor up front , clopidogrel , clopidogrel + aspirin , clopidogrel+aspirin , cloricromene , dipyridamol+Aspirin , dypiridamol , enoxaparin , indobufen , ketanserine , kétensérine , picotamide , prasugrel , Prasugrel and Bivalirudin , reloading clopidogrel , roxifiban , SCH 530348 , sulfinpyrazone , suloctidil , sulotroban , ticlopidine , triflusal , various ,
• abciximab in cardiovascular prevention
• acetylsalicylic acid lysinate in cardiovascular prevention
• ajoene in cardiovascular prevention
• aloxistatin in cardiovascular prevention
• Alprostadil in cardiovascular prevention
• anagrelide in cardiovascular prevention
• andrographolide in cardiovascular prevention
• argatroban in cardiovascular prevention
• Aspirin in cardiovascular prevention
• bepafant in cardiovascular prevention
• beraprost in cardiovascular prevention
• canadine in cardiovascular prevention
• carboprostacyclin in cardiovascular prevention
• cilostamide in cardiovascular prevention
• cilostazol in cardiovascular prevention
• clentiazem in cardiovascular prevention
• clopidogrel in cardiovascular prevention
• daltroban in cardiovascular prevention
• dauricine in cardiovascular prevention
• dazmegrel in cardiovascular prevention
• defibrotide in cardiovascular prevention
• Dipyridamole in cardiovascular prevention
• Disintegrins in cardiovascular prevention
• draflazine in cardiovascular prevention
• echistatin in cardiovascular prevention
• efegatran in cardiovascular prevention
• enfenamic acid in cardiovascular prevention
• Epoprostenol in cardiovascular prevention
• eptifibatide in cardiovascular prevention
• essential 303 forte in cardiovascular prevention
• fibrinopeptides gamma in cardiovascular prevention
• glycocalicin in cardiovascular prevention
• helenalin in cardiovascular prevention
• ibudilast in cardiovascular prevention
• ifetroban in cardiovascular prevention
• Iloprost in cardiovascular prevention
• indobufen in cardiovascular prevention
• jararhagin in cardiovascular prevention
• Ketanserin in cardiovascular prevention
• KW 3635 in cardiovascular prevention
• lamifiban in cardiovascular prevention
• magnolol in cardiovascular prevention
• mexidol in cardiovascular prevention
• Milrinone in cardiovascular prevention
• naftopidil in cardiovascular prevention
• nitroaspirin in cardiovascular prevention
• oxophenylarsine in cardiovascular prevention
• Pentoxifylline in cardiovascular prevention
• picotamide in cardiovascular prevention
• piroximone in cardiovascular prevention
• plafibride in cardiovascular prevention
• policosanol in cardiovascular prevention
• protopine in cardiovascular prevention
• pycnogenols in cardiovascular prevention
• Quin2 in cardiovascular prevention
• ramatroban in cardiovascular prevention
• relcovaptan in cardiovascular prevention
• resveratrol in cardiovascular prevention
• rhodostomin in cardiovascular prevention
• ridogrel in cardiovascular prevention
• rosmarinic acid in cardiovascular prevention
• S-nitrosocysteine in cardiovascular prevention
• S-Nitrosoglutathione in cardiovascular prevention
• S-nitrosomercaptoethanol in cardiovascular prevention
• S-Nitrosothiols in cardiovascular prevention
• sarpogrelate in cardiovascular prevention
• Satigrel in cardiovascular prevention
• sevoflurane in cardiovascular prevention
• sibrafiban in cardiovascular prevention
• sulotroban in cardiovascular prevention
• tautomycin in cardiovascular prevention
• thromboxane A2, carbocyclic in cardiovascular prevention
• Ticlopidine in cardiovascular prevention
• tirofiban in cardiovascular prevention
• tranilast in cardiovascular prevention
• Trapidil in cardiovascular prevention
• trequinsin in cardiovascular prevention
• triflavin in cardiovascular prevention
• triflusal in cardiovascular prevention
• trilinolein in cardiovascular prevention
• vapiprost in cardiovascular prevention
• xemilofiban in cardiovascular prevention
• naftopidil in Primary Prevention
• naftopidil in Secondary prevention
• naftopidil in cardiometabolic syndrom

Entry term : Primary Prevention, Secondary prevention, cardiometabolic syndrom, abciximab , acetylsalicylic acid lysinate , ajoene , aloxistatin , Alprostadil , anagrelide , andrographolide , argatroban , Aspirin , bepafant , beraprost , canadine , carboprostacyclin , cilostamide , cilostazol , clentiazem , clopidogrel , daltroban , dauricine , dazmegrel , defibrotide , Dipyridamole , Disintegrins , draflazine , echistatin , efegatran , enfenamic acid , Epoprostenol , eptifibatide , essential 303 forte , fibrinopeptides gamma , glycocalicin , helenalin , ibudilast , ifetroban , Iloprost , indobufen , jararhagin , Ketanserin , KW 3635 , lamifiban , magnolol , mexidol , Milrinone , naftopidil , nitroaspirin , oxophenylarsine , Pentoxifylline , picotamide , piroximone , plafibride , policosanol , protopine , pycnogenols , Quin2 , ramatroban , relcovaptan , resveratrol , rhodostomin , ridogrel , rosmarinic acid , S-nitrosocysteine , S-Nitrosoglutathione , S-nitrosomercaptoethanol , S-Nitrosothiols , sarpogrelate , Satigrel , sevoflurane , sibrafiban , sulotroban , tautomycin , thromboxane A2, carbocyclic , Ticlopidine , tirofiban , tranilast , Trapidil , trequinsin , triflavin , triflusal , trilinolein , vapiprost , xemilofiban ,

citeULike

This site complies to the HONcode standard for trustworthy health information: verify here.

Last uptaded on 2010/9 51 user(s) connected

TrialResults-center database by TrialResults-center is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France License .

OpenSearch feed - Add TrialResults-center.org to your browser's search bar